Treatment of diabetic patients with a stent and locally administered adjunctive therapy
AssigneeAbbott Cardiovascular Systems Inc.
InventorSyed F. A. Hossainy
Life of this patent
Estimating the term…
Abstract
Embodiments of the present invention include methods of treating, preventing, and/or ameliorating a vascular disease and/or disorder in a diabetic or pre-diabetic patient. The methods include implanting a stent in a vascular region in a diabetic or pre-diabetic patient, and prior to and/or during the implantation procedure, delivering a lubricant formulation to the vascular region. The stent may be a bare metal stent, or a drug eluting stent, such as a metal stent with a coating including a drug, such as everolimus or sirolimus.
Claims18
A method of treating, preventing, or ameliorating a vascular disease, a vascular disorder, or both in a diabetic or pre-diabetic patient, the method comprising:
- delivering a stent to, and deploying the stent at a vascular region of a patient;
- and
- prior to, during, or both prior to and during the deployment of the stent, administering a lubricant formulation to the vascular region of the patient;
- wherein the patient is identified as having a diabetic condition or a pre-diabetic condition;
- wherein the patient is in need of treating, preventing, or ameliorating a vascular disease, a vascular disorder, or both;
- wherein the lubricant formulation administration comprises delivery by a balloon, a dual balloon catheter, a balloon catheter, a guide catheter, a micro-catheter, or a combination thereof;
- wherein the lubricant formulation comprises at least one substance selected from the group consisting of collagen, starches, the homopolymer of acrylic acid, and combinations thereof;
- and
- wherein the lubricant formulation is a fluid that is free of drugs, wherein said drugs do not include said substances of the lubricant formulation.
Dependencies are inferred from the claim text.